Marker Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Marker Therapeutics

06/11/2024 13:50

* Marker Therapeutics Inc  MRKR.OQ   MRKR.O  is expected
to report
results for the period ending September 30 2024
    * The Houston Texas-based  company is expected to report
revenue
of $1 million, according to the estimate from one analyst, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Marker Therapeutics Inc
is for
a loss of 39 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Marker
Therapeutics Inc is $15.75​, above​ its last closing price
of $3.70. ​​​

This summary was machine generated November 6 at 13:50 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)